natgillin/translations-raw huggingface dataset:
hives (or "nettle rash"), itching, hair loss, eczema, dry skin, skin redness, acne an increase of CPK (creatine phosphokinase) in your blood, an enzyme which is sometimes released with muscle breakdown, muscle spasms, joint stiffness, muscle weakness, neck pain
urtikarija (koprivnica), srbenje, izpadanje las, ekcem, suha koža, pordelost kože, akne zvišana koncentracija kreatin kinaze (CPK) v krvi (encima, ki se včasih sprosti ob razpadanju mišic), mišični krči, okorelost sklepov, otekanje sklepov, šibkost mišic, bolečine v vratu
hives (or “nettle rash”), hair loss, eczema, acne an increase of CPK (creatine phosphokinase) in your blood, an enzyme which is sometimes released with muscle breakdown, muscle spasms, joint stiffness, joint swelling, muscle weakness, neck pain
izpuščaji (koprivnica), izpadanje las, ekcem, akne zvišana koncentracija CPK (kreatin fosfokinaze) v krvi; encima, ki se včasih sprosti ob razpadanju mišic, mišičnih krčih, okorelosti sklepov, otekanju sklepov, šibkosti mišic, bolečini v vratu
Hives (red bumps on your skin, that are sometimes itchy).
koprivnica (rdeči, izbokli kožni izpuščaji, ki lahko srbijo)
hives (urticaria)
izpuščaji (urtikarija),
hives (urticaria)
koprivnica (urtikarija)
Hives (urticaria)
koprivnica (urtikarija),
Hives (urticaria)
koprivnica (urtikarija);
Hives (urticaria)
Urtikarija (koprivnica)
hives (urticaria) dehydration.
koprivnica (utrikarija) dehidracija.
Hives (urticaria), redness and irritation (dermatitis) and itching (pruritus) at the vaccination-site; flushing
koprivnica (urtikarija), rdečina in draženje (vnetje kože) ter srbenje (pruritus) na mestu cepljenja; pordevanje
Hives (urticaria).
koprivnica (urtikarija),
hives rash
koprivnica, izpuščaj.
Hives, generalised itching
koprivnica, generalizirano srbenje,
hives, increased sweating, night sweats
koprivnica, močnejše znojenje, nočno znojenje
hives, increased sweating, night sweats
koprivnica, močnejše znojenje, nočno znojenje,
hives, inflammation of the skin, redness of the skin, dry skin, red or purple spots under the skin, skin color disorder, increased sweating
koprivnica, vnetje kože, rdečina kože, suha koža, rdeči ali vijolični podkožni madeži, sprememba barve kože, povečano potenje,
Hives, itching
koprivnica, srbenje,
Hives, itching
koprivnica, srbečica,
Hives, itching, increased sweating, dehydration
koprivnica, srbenje, povečano znojenje, dehidracija;
hives, rash, itching
koprivnica, izpuščaj, srbenje
Hives, rash, itching (pruritus)
koprivnica, izpuščaji, srbenje (pruritus);
Hives, red itchy bumps on your skin (urticaria)
Koprivke, rdeče, srbeče bulice na koži (koprivnica)
Hives.
koprivnica
hives.
koprivnica,
hives/ localised swelling of the skin or lining of the mouth or throat
izpuščaji/lokalizirano otekanje kože ali obloge v ustih ali grlu
Hives/nettle rash and itching
koprivnica/urtikarija in srbenje
Hives;
koprivnica
hives; swelling in your hands, feet, ankles, face, lips, mouth or throat which may cause difficulty in swallowing or breathing.
koprivnica; otekanje dlani, podplatov, gležnjev, obraza, ustnic, ust ali grla, ki lahko povzroča težave pri požiranju ali dihanju.
HIV1 patient isolates with reduced susceptibility to indinavir expressed varying patterns and degrees of cross–resistance to a series of diverse HIV PIs, including ritonavir and saquinavir.
Izolati bolnikov, okuženih s HIV-1, z zmanjšano občutljivostjo na indinavir, so kazali različne vzorce in stopnje navzkrižne rezistence na vrsto različnih zaviralcev HIV proteaze, vključno z ritonavirjem in sakvinavirom.
Hizentra 200 mg/ml solution for subcutaneous injection
Hizentra 200 mg/ml raztopina za subkutano injiciranje
Hizentra belongs to the class of medicines called human normal immunoglobulins.
Zdravilo Hizentra spada v razred zdravil, ki se imenujejo humani polispecifični imunoglobulini.
Hizentra comes as a ready-to-use solution in single-use vials.
Zdravilo Hizentra se dobavlja v obliki raztopine, pripravljene za uporabo, v vialah za enkratno uporabo.
Hizentra contains approximately 250 mmol/L (range: 210 to 290) of L-proline.
Zdravilo Hizentra vsebuje približno 250 mmol/l (razpon: 210 do 290) L-prolina.
Hizentra has no or negligible influence on the ability to drive and use machines.
Zdravilo Hizentra nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
Hizentra human normal immunoglobulin (SCIg)
Hizentra humani polispecifični imunoglobulin (s.c.Ig)
Hizentra is a ready-to-use solution (see section 5 “How to store Hizentra” and section 6 “What Hizentra looks like and contents of the pack”).
Zdravilo Hizentra je raztopina, ki je pripravljena za uporabo (glejte poglavje 5 »Shranjevanje zdravila Hizentra« in Poglavje 6 »Izgled zdravila Hizentra in vsebina pakiranja«).
Hizentra is a solution for injection under the skin.
Zdravilo Hizentra je raztopina za injiciranje v podkožje.
Hizentra is a solution for subcutaneous injection (200 mg/ml).
Zdravilo Hizentra je raztopina za subkutano injiciranje (200 mg/ml).
Hizentra is essentially sodium free.
Zdravilo Hizentra je v bistvu brez natrija.
Hizentra is given as a subcutaneous infusion (very
Zdravilo Hizentra se daje kot infuzija v podkožje (zelo počasno injiciranje v podkožje) na mestih, kot so trebuh, stegno, nadlaket ali kolk.
Hizentra is made from human blood plasma (this is the liquid part of the blood).
Zdravilo Hizentra je narejeno iz humane krvne plazme (tekočega dela krvi).
Hizentra may be injected into sites such as abdomen, thigh, upper arm, and lateral hip.
Zdravilo Hizentra se lahko injicira na mestih, kot so trebuh, stegna, nadlaket in lateralni del kolka.
Hizentra may impair the effect of some live virus vaccines such as measles, rubella, mumps and chicken pox.
 Zdravilo Hizentra lahko zmanjša učinkovitost nekaterih cepiv z živimi virusi, kot so cepiva proti ošpicam, rdečkam, mumpsu in noricam.
Hizentra must not be given intravascularly.
Zdravilo Hizentra se ne sme dajati intravaskularno.
Hizentra must not be used in patients with hyperprolinaemia (a genetic disorder causing high levels of the amino acid proline in the blood).
Zdravilo Hizentra se ne sme uporabljati pri bolnikih s hiperprolinemijo (genetsko motnjo, ki povzroča visoke ravni aminokisline prolin v krvi).
Hizentra was evaluated in 33 paediatric subjects (21 children [3 to 11 years] and 12 adolescents [12 to 16 years]) with primary immunodeficiency disease (PID).
Zdravilo Hizentra so ocenjevali pri 33 pediatričnih bolnikih (21 otrocih [od 3 do 11 let] in 12 mladostnikih [od 12 do 16 let]) z boleznijo primarne imunodeficience (PID).
Hizentra works by restoring abnormally low IgG levels to their normal range in the patient’s blood.
Zdravilo Hizentra deluje tako, da nenormalno nizko koncentracijo imunoglobulina v bolnikovi krvi povrne v območje njene normalne vrednosti.
HLA-A*3101 allele has a prevalence of 2 to 5% in European populations and about 10% in Japanese population.
Prevalenca alela HLA-A*3101 je med 2 in 5 % pri evropski populaciji in približno 10 % pri populaciji japonske narodnosti.
HLA-B*5701 status must always be documented prior to initiating therapy.
HLA-B*5701 status je vedno treba dokumentirati pred začetkom zdravljenja.
HLA-B*5701 status must always be documented prior to initiating therapy.
pred uvedbo terapije je treba vedno dokumentirati status HLA-B*5701.
HMG Co-A reductase
reduktaze je lahko potrebna
HMG Co-A Reductase Inhibitor
Zaviralec reduktaze HMG Co-A Lovastatin, simvastatin
HMG Co-A Reductase Inhibitor
Zaviralec reduktaze HMGCoA Lovastatin, simvastatin
HMG CO-A REDUCTASE INHIBITORS
ZAVIRALCI HMG CO-A REDUKTAZE
HMG Co-A Reductase Inhibitors
Zaviralci HMG Co-A-reduktaze
HMG CO-A REDUCTASE INHIBITORS
ZAVIRALCI HMG-COA REDUKTAZE
HMG CO-A REDUCTASE INHIBITORS
ZAVIRALCI REDUKTAZE HMG CoA
HMG Co-A Reductase Inhibitors
Zaviralci reduktaze HMG-CoA
HMG CoA REDUCTASE INHIBITOR
ZAVIRALCI REDUKTAZE HMG CoA
HMG CoA REDUCTASE INHIBITOR
ZAVIRALEC REDUKTAZE HMG CoA
HMG CoA REDUCTASE INHIBITORS
INHIBITORJI HMG CoA REDUKTAZE
HMG CoA reductase inhibitors
Zaviralci HMG CoA reduktaze
HMG-CoA reductase inhibitors
povečane, kadar se sočasno dajejo
HMG-CoA reductase inhibitors
Zaviralci HMG-CoA reduktaze
HMG-CoA REDUCTASE INHIBITORS
ZAVIRALCI REDUKTAZE HMG-CoA:
HMG-CoA reductase inhibitors
Zaviralci reduktaze HMGCoA
HMG-CoA reductase inhibitors may cause myopathy, including rhabdomyolysis, the combination of these agents with lopinavir/ritonavir is contraindicated (see section 4.3).
Uporaba avanafila z lopinavirjem/ritonavirjem je kontraindicirana (glejte poglavje 4.3).
HMG-CoA REDUCTASE INHIBITORS Same recommendations as for indinavir without ritonavir boosting (see Table 1).
ZAVIRALCI REDUKTAZE HMG CoA Enaka priporočila kot pri indinavirju, ki ni okrepljen z ritonavirjem (glejte tabelo 1).
hoarse voice
hripavost,
hoarseness
hripavost
hoarseness
hripavost,
hock
šok;
hock*, serum
erumska bolezen,
hock, intravascular administration of iodinated contrast agents (see section 4.4).
intravaskularna aplikacija jodiranih kontrastnih sredstev (glejte poglavje 4.4);
hock;
šok,
Hoddesdon, Hertfordshire, EN11 9BU United Kingdom
Hoddesdon, Hertfordshire EN11 9BU, Velika Britanija
Hodges-Lehmann point estimate of shift and 95% asymptotic (Moses) confidence interval.
Hodges-Lehmann točka ocene razlike in 95 % asimptotski (Moses) interval zaupanja.
HoFH (N = 96)
HoDH (N = 96)
Hold a 30 mg capsule upright over one of the bowls and carefully snip off the rounded tip with scissors.
30 mg kapsulo držite navpično nad posodo in s škarjami odrežite zaobljeno konico.
Hold a 30 mg capsule upright over one of the bowls and carefully snip off the rounded tip with scissors.
30-mg kapsulo držite navpično nad posodo in s škarjami odrežite zaobljeno konico.
Hold a 45 mg capsule upright over one of the bowls and carefully snip off the rounded tip with scissors.
45 mg kapsulo držite navpično nad posodo in s škarjami odrežite zaobljeno konico.
Hold a 45 mg capsule upright over one of the bowls and carefully snip off the rounded tip with scissors.
45-mg kapsulo držite navpično nad posodo in s škarjami odrežite zaobljeno konico.
Hold a 75 mg capsule upright over one of the bowls and carefully snip off the rounded tip with scissors.
75 mg kapsulo držite navpično nad posodo in s škarjami odrežite zaobljeno konico.
Hold a 75 mg capsule upright over one of the bowls and carefully snip off the rounded tip with scissors.
75-mg kapsulo držite navpično nad posodo in s škarjami odrežite zaobljeno konico.
Hold a pad firmly over the injection site on your outstretched arm for about 2 minutes.
Držite roko iztegnjeno in na mestu vboda še približno dve minuti pritiskajte blazinico.
Hold a pad firmly over the injection site on your outstretched arm for approximately 2 minutes.
Držite roko iztegnjeno in na mestu vboda še približno dve minuti pritiskajte blazinico.
Hold a swab firmly over the injection site on the outstretched arm for approx.
Držite roko iztegnjeno in na mestu vboda še dve minuti pritiskajte blazinico.
Hold a swab on the injection site.
Na mesto injiciranja pritisnite blazinico.
Hold Avonex Pen so that the cap is pointing up.
Napolnjen injekcijski peresnik Avonex Pen držite z
Hold bosutinib until ANC  1.0×109/L and platelets  50×109/L.
Zdravljenje z bosutinibom prekinite, dokler ni ANC  1,0 x 109/l in število trombocitov  50 x 109/l.
Hold bottle and syringe securely tight.
Varno držite steklenico in brizgo.
Hold down dosing button until beeping stops and display goes blank
Držite gumb za odmerjanje, dokler piskanje ne preneha in prikaz izgine.
Hold down dosing button until display goes blank
Držite gumb za odmerjanje, dokler vsebina na prikazovalniku ne izgine.
Hold firmly.
Trdno primite kožno gubo.
Hold gauze on the injection site for approximately 30 seconds.
Na vbodno mesto za približno 30 sekund pritisnite kos gaze.
Hold InnoLet with the needle upwards and tap the cartridge gently with your finger a few times (picture B) to make any air bubbles collect at the top of the cartridge.
Držite injekcijski peresnik InnoLet tako, da je igla obrnjena navzgor, in s prstom nekajkrat rahlo potrkajte po injekcijskem vložku (slika B), da se bodo zračni mehurčki zbrali na vrhu injekcijskega vložka.
Hold it in and count to 5 s-l-o- w-l-y.
Držite ga pritisnjenega in p-o-č-a-s-i štejte do 5.
Hold it in and count to 5 s-l-o-w-l-y.
Držite ga pritisnjenega in p-o-č-a-s-i štejte do 5.
Hold needle either vertically (90°) or at a 45° angle to the skin and insert it under the skin as far as it will go in one quick motion.
Iglo postavite v navpičen položaj (90°) ali pod kotom 45° stopinj glede na kožo in jo z enim hitrim gibom potisnite pod kožo, kolikor globoko lahko.
Hold RebiDose at a right angle (90 degrees) to the injection site.
Peresnik RebiDose držite pravokotno na mesto injiciranja (90°).
Hold RebiDose by the main body and use your other hand to remove the cap.
Peresnik RebiDose primite za osrednji del in z drugo roko odstranite zaporko.
Hold RebiSlide firmly and slide the release button which is on the side of the device.
Trdno držite pripomoček RebiSlide in potisnite sprožilni gumb, ki je ob strani pripomočka.
Hold sachet of granules with cut line on top.
Primite vrečico z zrnci s prekinjeno črto na vrhu.
Hold syringe between 45-90 degrees angle to skin with needle facing the skin.
Brizgo držite pod kotom med 45 in 90 stopinjami glede na kožo, igla pa naj bo obrnjena proti koži.
Hold syringe upright and advance plunger rod slowly to expel the air.
Injekcijsko brizgo držite pokonci in počasi pritiskajte na potiskalo bata, da iztisnete zrak.
Hold the ampoule upright and tap lightly before twisting off the head part to avoid spilling.
Ampulo držite pokonci in po njej rahlo potapkajte, preden ji odtrgate glavo; pazite, da ne polijete.
Hold the barrel of the syringe with one hand and pull the needle cover straight off.
Držite valj brizge z eno roko in potegnite pokrovček igle naravnost proč.
Hold the black ring at the bottom of the base and use it to pull the base out of the chamber.
Vtaknite kazalec v črni obroč na spodnjem delu inhalatorja in ga povlecite, s čimer boste potegnili podnožje iz komore.
Hold the blister strip at the edges and separate one blister cell from the rest of the strip by gently tearing along the perforations around it.
Primite pretisni omot na robovih in ločite en pretisni razdelek od ostalih razdelkov omota tako, da ga rahlo odtrgate vzdolž perforacij okoli njega.
Hold the blister tray and put the vial adapter on top of the powder vial.
Primite pretisni omot in položite adapter na vrh viale s praškom.
Hold the blister tray by the top.
Pretisni omot primite za njegov zgornji del.
Hold the blister tray firmly.
Pretisni omot čvrsto držite.
Hold the body of the pen at a right angle to the injection site with one hand.
Z eno roko držite ohišje napolnjenega injekcijskega peresnika pod pravim kotom na mesto injiciranja.
Hold the body of the pen firmly with one hand.
Ohišje napolnjenega injekcijskega peresnika čvrsto držite z eno roko.
Hold the bottle upside down in one hand and use the other hand to fill the oral syringe.
Z eno roko držite steklenico navzdol, z drugo pa napolnite peroralno brizgo.
Hold the bottle, pointing down, between your thumb and fingers
Kapalni vsebnik držite med palcem in prsti, obrnjen navzdol.
Hold the bottle, pointing down, between your thumb and fingers
Kapalni vsebnik držite s palcem in prsti, obrnjeno navzdol.
Hold the bottle, pointing down, between your thumb and fingers.
Kapalni vsebnik držite med palcem in prsti, obrnjen navzdol.
Hold the bottle, pointing down, between your thumb and fingers.
Plastenko, obrnjeno navzdol, primite s palcem in kazalcem.
Hold the bottle, pointing down, between your thumb and middle finger
Kapalni vsebnik držite s palcem in sredincem, obrnjenega navzdol.
Hold the bottle, pointing down, between your thumb and middle finger.
Kapalni vsebnik držite obrnjeno navzdol s palcem in sredincem.
Hold the bottle, pointing down, between your thumb and middle finger.
Kapalni vsebnik držite s palcem in sredincem, obrnjeno navzdol.
Hold the bottle.
Držite stekleničko.
Hold the bottom of the inhaler firmly with one hand.
Z eno roko trdno primite dno inhalatorja.
Hold the breath bag upright and stick the bar-code label marked “00-minute-value” on the breath bag.
Vrečko držite pokonci in nanjo prilepite etiketo s črtno kodo z napisom "00-minutna vrednost".
Hold the catheter at its base using a sterile technique, pinch and hold the skinfold cranial to, or overlying the patient’s supra-iliac crest with two fingers.
S sterilno tehniko primite kateter na njegovem korenu in s prstoma stisnite ter primite kožno gubo na mestu, ki je nad ali prekriva bolnikovo suprailiakalno kristo.
Hold the container between your thumb and fingers with the open end pointing down.
Vsebnik držite s palcem in kazalcem, z odprtim koncem obrnjenim navzdol.
Hold the Controller in one hand and pull the red tab with the other hand to separate the hydrogel housing from the system.
Držite upravljalnik v eni roki in povlecite rdeči zavihek z drugo roko, da ločite hidrogelno ohišje od sistema.
Hold the dose knob down for a minimum of 5 seconds to ensure you inject the full dose (2).
Gumb za odmerek držite navzdol vsaj 5 sekund, da injicirate celotni odmerek (2).
Hold the dosing pump onto the neck of the bottle and screw it clockwise until it fits firmly (fig.
Odmerno črpalko držite na vratu stekleničke in jo obračajte v smeri urnega kazalca, dokler se tesno ne prilega (sl.
Hold the filled syringe by the base.
Primite napolnjeno injekcijsko brizgo za podnožje.
Hold the fold of skin, bring the syringe to the skin and quickly insert the needle into the skin fold.
Držite kožno gubo, brizgo približajte koži in iglo hitro vstavite v kožno gubo.
Hold the Genuair inhaler horizontally with the mouthpiece towards you and the green button facing straight up (see image 2).
Inhalator Genuair držite vodoravno, tako da bo ustnik obrnjen proti vam, zeleni gumb pa bo obrnjen naravnost navzgor (glejte sliko 2).
Hold the Genuair inhaler horizontally with the mouthpiece towards you and the orange button facing straight up (see image 2).
Inhalator Genuair držite vodoravno, tako da bo ustnik obrnjen proti vam, oranžni gumb pa bo obrnjen naravnost navzgor (glejte sliko 2).
Hold the GONAL-f pre-filled pen firmly with one hand, and slip the needle into the outer needle cap.
Držite GONAL-f napolnjen injekcijski peresnik čvrsto z eno roko in potisnite iglo v zunanji pokrovček za iglo.
Hold the GONAL-f pre-filled pen with the needle pointing upward.
Držite GONAL-f napolnjeni injekcijski peresnik z iglo navzgor.
Hold the handset level and place the mouthpiece in your mouth and close your lips around it (Figure 3).
Komplet z nebulatorjem držite ravno, dajte ustnik v usta in okoli njega zaprite ustnice (slika 3).
Hold the handset level, press and hold the on/off button on the controller for a few seconds.
Nebulator držite ravno ter pritisnite in za nekaj sekund držite gumb za vklop/izklop na krmilniku.
Hold the inhaler upright and fully press in both ‘Piercing’ buttons on the sides of the inhaler at the same time, then release them.
Inhalator držite pokonci in sočasno pritisnite oba gumba za prediranje na straneh inhalatorja do konca, nato pa ju izpustite.
Hold the inhaler upright with the mouthpiece pointing up.
Inhalator držite pokonci z ustnikom obrnjenim navzgor.
Hold the insulin blister by the tab with printed side up with the notch pointed towards the insulin inhaler, insert the blister.
Primite insulinski pretisni omot za jeziček s potiskano stranjo navzgor in z zarezo obrnjeno proti insulinskemu inhalatorju, ter vložite pretisni omot v odprtino.
Hold the long flat end of the container between your thumb and forefinger and open it by twisting off the other end (picture 2).
Držite dolgi, raven konec vsebnika med palcem in kazalcem in ga odprite tako, da zvijete in odtrgate drugi konec (slika 2).
Hold the nasal spray upright, then tilt and point the nozzle away from you.
Držite nosno pršilo pokonci, potem ga nagnite in usmerite šobo proč od sebe.
Hold the nasal spray upright, then tilt and point the nozzle away from you.
Držite pršilo za nos pokonci, potem ga nagnite in usmerite nastavek proč od sebe.
Hold the nasal spray upright.
Pršilo držite pokonci.
Hold the needle-shield of the syringe firmly with one hand and pull off the needle-cap with the other hand. (See Fig.
Z eno roko trdno primite varovalo injekcijske igle, z drugo povlecite pokrovček injekcijske igle (glejte sliko D).
Hold the OPC (One-Point-Cut) ampoule with the blue point upwards.
Držite ampulo OPC (one point cut) z modro piko kvišku.
Hold the oral syringe with the tip pointing up.
Brizgo za peroralno dajanje držite pokonci, z vrhom navzgor.
Hold the oral syringe with the tip pointing upward.
Brizgo za peroralno dajanje držite pokonci, z vrhom navzgor.
Hold the other half of the rigid release liner and put the sticky surface of the patch onto your skin.
Primite drugo polovico trdne zaščitne plasti in namestite lepljivo površino obliža na kožo.
Hold the outer needle cap firmly.
Trdno držite zunanji pokrovček igle.
Hold the patch in both hands with the release liner facing you.
Obliž primite v roke, tako da je zaščitna plast obrnjena proti vam.
Hold the pen as shown in this leaflet.
Injekcijski peresnik primite tako , kot je prikazano v tem navodilu za uporabo.
Hold the pen at 90 degrees to the cleaned injection site.
Injekcijski peresnik držite pravokotno nad očiščenim mestom injiciranja (pod kotom 90 stopinj).
Hold the pen body with the clear cartridge pointing up so that you can see the [1] in the number window.
Držite telo peresnika tako, da je prozorni vložek obrnjen navzgor in lahko vidite [1] v številčnem okencu.
Hold the pen by the barrel and turn the reservoir in the direction as indicated by the arrow in Diagram J (clockwise) until you feel it click.
Peresnik držite za telo in rezervoar obračajte v smeri puščice na sliki J (t.j. v smeri urnega kazalca), dokler ne začutite klika.
Hold the pen by the end with the orange label and tap the pen firmly against the palm of your hand.
Držite peresnik na koncu z oranžno nalepko in z njim odločno potrkavajte ob dlan.
Hold the pen with needle pointing Upright.
Injekcijski peresnik držite tako, da je igla obrnjena navzgor.
Hold the pen with the clear cartridge pointing up
Držite peresnik tako, da je prozorni vložek obrnjen navzgor.
Hold the pen with the injection needle point upwards.
Peresnik z injekcijsko iglo držite pokonci.
Hold the pen with the needle end pointing down.
Peresnik držite tako, da stran z iglo gleda naravnost dol.
Hold the pen with the needle pointing up.
Držite injekcijski peresnik tako, da je igla obrnjena navzgor.
Hold the pen with the needle pointing up.
Injekcijski peresnik držite z iglo obrnjeno navzgor.
Hold the pen with the needle pointing upright.
Injekcijski peresnik držite tako, da je igla obrnjena navzgor.
Hold the pen with the needle pointing upwards.
Primite injekcijski peresnik tako, da je igla obrnjena navzgor.
Hold the PINCH.
DRŽITE kožno gubo.
Hold the pipette in an upright position.
Postavite jo pokonci.
hold the plastic cap under the needle protector tighten the needle and cap by slightly turning and pushing it towards the syringe.
držite plastični pokrov pod igelno zaščito, iglo s pokrovom pritrdite z rahlim obratom in potiskanjem proti injekcijski brizgi.
hold the plastic cap under the needle protector tighten the needle and cap with a gentle clockwise twist.
držite plastični pokrov pod igelno zaščito, iglo s pokrovom pritrdite z rahlim zavojem v smeri urinega kazalca.
Hold the plastic tube, break the seal at one end and pull the cap off.
Primite plastični ovitek, prelomite pečat na enem koncu in odstranite pokrovček.
Hold the Plegridy syringe at a 90° angle to the injection site.
Injekcijsko brizgo z zdravilom Plegridy držite pod kotom 90° na mesto injiciranja.
Hold the plunger and unscrew the syringe.
Primite za bat in odvijte brizgo.
Hold the plunger with your right hand and unlock the ring-stop by turning it towards you.
Držite bat z desno roko in odklenite zaporni obroček tako, da ga zasukate proti sebi.
Hold the powder vial on the clean and flat surface.
Vialo s praškom položite na čisto in ravno površino.